Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 12.82
+0.14 (1.10%)
Aug 15, 2025, 10:45 AM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 20.28 billion as of August 14, 2025. Its market cap has increased by 9.07% in one year.
Market Cap
20.28B
Enterprise Value
19.30B
Revenue
2.68B
Ranking
n/a
PE Ratio
153.98
Stock Price
12.82
Market Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 20.28B, an increase of 48.73%. That is a compound annual growth rate of 2.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 20.28B | 4.97% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | 59.52B | 19.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 407.67B |
| Shenzhen Mindray Bio-Medical Electronics | 283.36B |
| WuXi AppTec | 267.34B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.37B |
| Aier Eye Hospital Group | 120.66B |
| Sichuan Biokin Pharmaceutical | 118.80B |
| Shanghai United Imaging Healthcare | 107.16B |
| Yunnan Baiyao Group Co.,Ltd | 99.83B |